Early capillary no-reflow during low-flow reperfusion after hind limb ischemia in the rat

Annals of Plastic Surgery

Volumn 49, Issue 2, 2002, Pages 170-180

  Fitzal, Florian ^a,b   DeLano, Frank A ^a   Young, Corey ^a   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; DIAGNOSTIC AGENT; FLUORESCENT DYE; GABEXATE; SERINE PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTICLE; CAPILLARY FLOW; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; GRACILIS MUSCLE; GRAFT FAILURE; HINDLIMB; LEUKOCYTE ADHERENCE; LIMB ISCHEMIA; MALE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; REPERFUSION INJURY; THROMBOCYTE AGGREGATION; ANIMAL; CAPILLARY RESISTANCE; DRUG EFFECT; ERYTHROCYTE; EVALUATION; FEMORAL ARTERY; FLUORESCENCE MICROSCOPY; HEMODYNAMICS; IMMUNOLOGY; LEUKOCYTE; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION; WISTAR RAT;

ANIMALS; CAPILLARY RESISTANCE; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; FEMORAL ARTERY; FLUORESCENT DYES; GABEXATE; HEMODYNAMIC PROCESSES; HINDLIMB; LEUKOCYTES; MALE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; RATS; RATS, WISTAR; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS;

EID: 0036022298     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200208000-00010     Document Type: Article

References (34)

1. Experimental study of the relationship between alterations in tissue perfusion and anastomotic patency
2. No reflow after cerebral ischaemia
3. The significance of local vascular phenomena in the production of ischemic necrosis in skeletal muscle
4. The influence of arterial inflow and venous outflow in the survival of reversed-flow island flaps: An experimental study
5. The effect of intense arterial constriction on the survival length of an island flap: An experiment using abdominal flaps in rats
6. Blood flow velocity as a factor in postoperative microvascular patency
7. Low-flow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation
8. Leukocyte sequestration in the microvasculature in normal and low flow states
9. Systemic blood acidosis in low-flow ischemia induces capillary luminal narrowing
10. Rheology in the microcirculation in normal and low flow states
11. Low flow enhances platelet activation after acute experimental arterial injury
12. Pharmakologische grundlagen zur therapeutischen anwendbarkeit von gabexat mesylate (FOY)
13. The leukocyte response to fluid stress
14. Leukocyte cytoskeletal structure determines capillary plugging and network resistance
15. P-selectin and ICAM-1-dependent adherence reactions: Role in the genesis of postischemic no-reflow
16. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation
17. Inhibition of polymorphonuclear leukocyte adherence suppresses noreflow after focal cerebral ischemia in baboons
18. The effect of CY1503, a sialyl Lewis analog blocker of the selectin adhesion molecules, on infarction size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion
19. The effect of mannitol versus dimethyl thiourea at attenuating ischemia/reperfusion-induced injury in skeletal muscle
20. Combined therapy with antithrombotic agents and radical scavengers for reperfusion injury of flap
21. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine
22. Superoxide dismutases and anti-oxidants protected mice from no-reflow and necrotic damage induced by ischemia
23. The no-reflow phenomenon: A light at the end of the tunnel?
24. Leukocyte adhesion, edema, and development of postischemic capillary no-reflow
25. Biomechanics of skeletal muscle capillaries: Hemodynamic resistance, endothelial distensibility, and pseudopod formation
26. Venous congestion and blood flow in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps
27. Factors affecting fat necrosis and partial flap loss in DIEP flap breast reconstruction
28. Comparison of skeletal muscle microcirculation between clamp ischemia and microsurgical ischemia
29. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy
30. Use of anti-ICAM-1 therapy in ischemic stroke
31. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group
32. An anti CD11/CD18 monoclonal antibody on patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study)
33. Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis
34. Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department